allogenic effect factor (AEF)

soluble mediator from histocompatible cell interactions which induces cytotoxic T-lymphocytes in vitro; glycoprotein composed of 2 subunits 40,000 & 12,000 daltons; possesses Ia antigen
Also Known As:
AEF; allogeneic factor; serum allogenic factor
Networked: 240 relevant articles (12 outcomes, 14 trials/studies)

Relationship Network

Bio-Agent Context: Research Results


1. Lee, Jeong Min: 4 articles (01/2013 - 02/2009)
2. Kim, Kyung Won: 4 articles (01/2013 - 02/2009)
3. Klotz, Ernst: 4 articles (01/2013 - 02/2009)
4. Han, Joon Koo: 4 articles (01/2013 - 02/2009)
5. Choi, Byung Ihn: 4 articles (01/2013 - 02/2009)
6. Kawabata, Yoshinori: 3 articles (05/2015 - 04/2013)
7. Saiki, Yoshikatsu: 3 articles (03/2015 - 05/2012)
8. Kamel, Ihab R: 3 articles (11/2014 - 11/2012)
9. Bonekamp, Susanne: 3 articles (11/2014 - 11/2012)
10. Bonekamp, David: 3 articles (11/2014 - 11/2012)

Related Diseases

1. Aneurysm (Aneurysms)
2. Wounds and Injuries (Trauma)
07/01/1989 - "We have now been able to trace the process of tinnitus remission in one exemplary case during a period of 256 days after acute onset of tinnitus (due to a noise trauma), in which the amplitude ratio recovered from 0 to a normal value of approximately 1. This very first objectification of tinnitus remission strongly supports our hypothesis and indicates that AEF may become an indispensable, invaluable tool in both tinnitus research and management."
01/01/2015 - "Depending on the MDCT findings, the esophageal injuries were divided into four grades: Grade I, non-penetrating injury (six patients); Grade II, penetrating injury with minimal infection (five patients); Grade III, potential AEF (five patients); and Grade IV, definite AEF (six patients). "
01/01/2015 - "The authors' experience indicates that MDCT was useful to classify esophageal injuries caused by foreign body ingestion which predicted the risk of AEF; endovascular stent grafting and VATS-guided mediastinal drainage would be a safe and minimally invasive method for treating patients with AEF and has the potential for improved treatment options for AEFs."
01/01/1998 - "Our experience of this case suggests that primary closure for defects in both the aorta and the esophagus is the best option when the defects are small, and that the possibility of an AEF must be considered in patients with midthoracic pain or hematemesis, even if there is no history of thoracic aortic aneurysm, foreign body ingestion, trauma, or esophageal disease."
3. Infection
4. Foreign Bodies (Foreign Body)
5. Hematemesis

Related Drugs and Biologics

1. Amyloid (Amyloid Fibrils)
2. Biological Markers (Surrogate Marker)
3. Caseins (Casein)
4. amyloid enhancing factor
5. Ubiquitin
6. Silver Nitrate
7. Serum Amyloid A Protein (Serum Amyloid A)
8. Interleukin-18 (Interleukin 18)
9. Tacrolimus (Prograf)
10. Transforming Growth Factor beta (TGF-beta)

Related Therapies and Procedures

1. Transplants (Transplant)
2. Stents
3. Transplantation (Transplant Recipients)
4. Homologous Transplantation (Allograft)
5. Prostheses and Implants (Prosthesis)